Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

19.60HKD
23 Feb 2018
Change (% chg)

HK$0.34 (+1.77%)
Prev Close
HK$19.26
Open
HK$19.40
Day's High
HK$19.60
Day's Low
HK$19.22
Volume
6,591,500
Avg. Vol
5,631,973
52-wk High
HK$23.60
52-wk Low
HK$18.20

Latest Key Developments (Source: Significant Developments)

Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 2607.HK::‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​.‍NET PROCEEDS FROM PLACING EXPECTED TO BE HK$3,116.79 MILLION​.PROCEEDS TO FUND DEVELOPMENT OF PHARMACEUTICAL MANUFACTURING & DISTRIBUTION BUSINESSES & REPLENISH ITS WORKING CAPITAL​.  Full Article

Shanghai Pharmaceuticals Holding units receive GMP certificate
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line .Says the valid period is until Dec. 25, 2022.Says Shanghai-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for its products including flurbiprofen axetil .Says the valid period is until Dec. 26, 2022 .  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug .Says the valid period is until Dec. 25, 2022.  Full Article

Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​.  Full Article

Shanghai Pharmaceuticals Holding To Transfer Entire Stake In Shanghai Huashi Asset Management
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍TRANSFER OF 100% EQUITY INTEREST IN SHANGHAI HUASHI ASSET MANAGEMENT CO TO A CONTROLLING SHAREHOLDER​.DEAL FOR RMB218.1 MILLION​.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pill and Chinese medicine extraction workshop of the unit and the valid period is until Nov. 30, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Tuesday, 5 Dec 2017 

Dec 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> : :Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 27, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Sunday, 3 Dec 2017 

Dec 3(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 21, 2022.  Full Article

Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Cardinal Health Inc -:Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma.Deal for $1.2 bln‍​.‍Does not include Cardinal's remaining businesses in China, including Cordis, its medical sourcing team.‍Sale includes Cardinal Health's pharmaceutical and medical products distribution business in China​.‍Eric Zwisler, chairman of Cardinal Health China, will retire effective immediately as part of sale​.  Full Article

Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million.  Full Article

Shanghai Pharmaceuticals plans $400 mln share sale to fund production

HONG KONG, Jan 19 Shanghai Pharmaceuticals Holding Co Ltd said on Friday it planned to sell HK$3.13 billion ($400 million) worth of new shares to fund the development of its manufacturing and distribution businesses.